Contrast-enhanced ultrasound imaging using long-circulating cationic magnetic microbubbles in vitro and in vivo validations

Traditional encapsulated microbubbles are recently used as delivery carriers for drugs and genes, but they have low efficiency. If the local microbubble concentration could be increased, this might be able to improve the therapeutic efficacy of diseases. In this study, we developed novel cationic magnetic microbubbles (MB M ), which could simultaneously realize targeted aggregation under a magnetic field as well as ultrasonographic real-time visualization. Their physicochemical properties, biocompatibility , ultrasonography, magnetic response characteristics, and biodistribution were systematically evaluated. Here, the MB M were 2.55 ± 0.14 µm in size with a positive zeta potential , and had a good biocompatibility. They were able to enhance ultrasonographic contrast both in vitro and in vivo. MB M could be attracted by an external magnet for directional movement and aggregation in vitro. We confirmed that MB M also had a great magnetic response in vivo, by means of fluorescence imaging and contrast-enhanced ultrasound imaging. Following intravenous injection into tumor-bearing mice, MB M showed excellent stability in the internal circulation, and could accumulate in the tumor vasculature through magnetic targeting. With the excellent combination of magnetic response and acoustic properties, cationic magnetic microbubbles (MB M ) have promising potential for use as a new kind of drug/gene carrier for theranostics in the future.